Fingerprint
Dive into the research topics of 'Targeted MET inhibition in castration-resistant prostate cancer: A randomized phase II study and biomarker analysis with rilotumumab plus mitoxantrone and prednisone'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically